NL-OMON41526已完成不适用
Sickle Cell Disease: Targeting Alloantibody formation Reduction (STAR) - Risk factors for alloantibody formation - STAR
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •- Sickle Cell Disease (phenotypes HbSS, HbSC, HbS*+, HbS*0 or HbSE)
- •- History of at least 1 RBC transfusion in one of the participating centers
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Sickle Cell Disease: Targeting Alloantibody formation Reduction; RIsk factors, aNd GeneticsSickle Cell Anemia1001890210005330Sickle Cell DiseaseNL-OMON50758Sanquin Bloedbank150
Unknown
不适用
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and GeneticsAlloimmunizationSickle Cell DiseaseNCT03288012Sanquin Research & Blood Bank Divisions150
招募中
不适用
Sickle Cell Outcome ResearchSickle cell diseaseNL-OMON29491A1,000
招募中
不适用
Sickle Cell Outcome REsearchSickle cell DiseaseNL-OMON55241Erasmus MC, Universitair Medisch Centrum Rotterdam1,000
尚未招募
不适用
Acetylcysteine for Treatment of Sickle Cell Diseasesickle cell disease10018902NL-OMON30544Academisch Medisch Centrum10